Profadol
Profadol is an opioid analgesic which was developed in the 1960s by Parke-Davis[1]. It acts as a mixed agonist-antagonist of the μ-opioid receptor. The analgetic potency is about the same as of meperidine, the antagonistic effect is 1/50 of Nalorphine.[2]
See also
References
- ^ DE Patent 1303096
- ^ Eberhard Schröder, Clemens Rufer, Ralph Schmiechen, Arzneimittelchemie I, Georg Thieme Verlag 1976 ISBN 3 13 520601 7
|
|
|
Opioids
See also: Opioids template |
|
Opium & alkaloids thereof
|
|
|
|
Semi-synthetic opium
derivatives
|
|
|
|
Synthetic opioids
|
|
|
|
| Pyrazolones |
|
|
| Cannabinoids |
|
|
| Anilides |
|
|
Non-steroidal
anti-inflammatories
See also: NSAIDs template |
|
Propionic acid class
|
|
|
|
Oxicam class
|
|
|
|
Acetic acid class
|
|
|
|
|
|
|
|
Anthranilic acid
(fenamate) class
|
|
|
|
|
|
|
|
Atypical, adjuvant and potentiators,
Metabolic agents and miscellaneous |
|
|
|
|
|
|
|
anat(n/s/m/p/4/e/b/d/c/a/f/l/g)/phys/devp
|
noco(m/d/e/h/v/s)/cong/tumr, sysi/epon, injr
|
proc, drug(N1A/2AB/C/3/4/7A/B/C/D)
|
|
|
|